Term
|
Definition
| Beta Blocker -- Non-selective. HTN, Angina, cardiac dysrhythmias, MI. Blocks glycogenolysis and unsafe for pts with Diabetes or ASTHMA (bronchiconstrction) |
|
|
Term
|
Definition
| Beta Blocker -- selective. PRIMARILY Hypertension, also Angina, heart failure and MI. Safer than Propranolol for diabetes. |
|
|
Term
|
Definition
| Calcium Channel Blocker NON dihydropiridine. Decreases O2 demand of heart by dilating arterioles which decreases afterload and by decreasing heart rate (supress SA node). ANGINA, HTN, cardiac dysrhythmias. Hypotension, reflexive tachycardia. Increases levels of DIGOXIN as well as supress DIG efforts to increase contractility. |
|
|
Term
|
Definition
| Calcium channel blocker (dihydropiridine--vasodil only). Increases Digoxin levels. HTN and ANGINA. |
|
|
Term
|
Definition
| IHI platelet [blocks ADP receptors on platelets] aggregation/antiplatelet drug. Prevents stenosis of coronary stents.More expensive than Aspirin works only slightly better. Generally well tolerated (small % w GI upset) |
|
|
Term
| Aspirin (as an antiplatelet, ASA) |
|
Definition
| Cyclooxegenase ihi/Thomboxane2A ihi, antiplatlet. Reduces the risk of MI, stroke, angina. |
|
|
Term
|
Definition
| Antidysrhythmic. ONLY for life threatening a/v dysrhthmias. highly lipid soluable LONG HALF LIFE (days-months) and accumulates to toxic levels in liver and lungs causing PULMONARY TOXICITY, CARDIOTOXICITY |
|
|
Term
|
Definition
| ACE IHI, acts on arteriole and veins. COUGH, hypotension, angioedema, hyperkalemia. SERIOUS FETAL HARM. |
|
|
Term
|
Definition
| Cardiac glycoside. Increase contractility. Indicated for heart failure and cardiac dysrhythmias. Can cause dysrhythmias secondary to excessive LOSS of potassium. Narrow therapuetic range. Other drugs that increase/dec potassium levels can either cause toxicity or neg effects of dig--toxicity to heart, GI and CNS. |
|
|
Term
|
Definition
| ARB; vasodilator. can cause HYPERkalemia. |
|
|
Term
| Spironolactone (Aldactone) |
|
Definition
| Non selective aldosterone receptor antagonist, K sparing. |
|
|
